Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex
Open Access
- 1 April 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (7), 1518-1522
- https://doi.org/10.1111/j.1476-5381.1995.tb13379.x
Abstract
1 The pharmacological properties and location of H3 receptors modulating acetylcholine release have been investigated in non-superfused slices and synaptosomes of rat entorhinal cortex preloaded with [3H]-choline. 2 (R)α-methylhistamine, an H3-receptor agonist, potently inhibited the K+-evoked tritium release from slices, an effect antagonized by thioperamide, an H3-receptor antagonist, with nanomolar potency. 3 The K+-evoked tritium release from synaptosomes remained unaltered in the presence of the potent and selective H3-receptor agonists, imetit and (R)α-methylhistamine, suggesting that H3 receptors modulating acetylcholine release are not presynaptically located on cholinergic nerve terminals. 4 Phenylbutanoylhistamine and phenylpropylhistamine, two H3-receptor antagonists of moderate potency, failed to antagonize the inhibitory effects of (R)α-methylhistamine observed in slices. Unexpectedly, both compounds when used alone, inhibited tritium release from slices and synaptosomes with micromolar potency and to the same extent (by approximately 50% when added at a final concentration of 200 μm). This inhibitory effect did not involve H1, H2 or H3 receptors and was not mediated by an unknown histamine receptor site, since histamine used at a high concentration neither reproduced nor antagonized the effect of phenylbutanoylhistamine. It remained unaltered in the presence of scopolamine and was neither mimicked nor antagonized by vasoactive intestinal peptide, previously shown to be colocalized with acetylcholine in some neurones. 5 It is concluded that acetylcholine release in rat entorhinal cortex is modulated by H3 receptors presumably not located on cholinergic axon terminals. It remains to be established whether these H3 receptors belong to a receptor subtype different from those previously described since the potency of phenylbutanoylhistamine and phenylpropylhistamine as H3-receptor antagonists was probably greatly underestimated by additional properties of both drugs.Keywords
This publication has 32 references indexed in Scilit:
- Histaminergic Modulation of Hippocampal Acetylcholine Release In VivoJournal of Neurochemistry, 1994
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJournal of Neural Transmission, 1993
- Regulation of histamine release in rat hypothalamus and hippocampus by presynaptic galanin receptorsPeptides, 1991
- High affinity histamine binding site is the H3 receptor: Characterization and autoradiographic localization in rat brainSynapse, 1991
- Biexponential Kinetics of (R)‐α‐[3H]Methylhistamine Binding to the Rat Brain H3 Histamine ReceptorJournal of Neurochemistry, 1990
- Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cationsEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Highly potent and selective ligands for histamine H3-receptorsNature, 1987
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- SOME PROPERTIES OF SYNAPTIC MEMBRANES ISOLATED FROM THE CENTRAL NERVOUS SYSTEM*Annals of the New York Academy of Sciences, 1966